Save time and get answers to complex questions with AI chat
Dabrafenib patent expiration?Somatuline depot patent expiry date?Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?Testosterone enanthate expiration?Drugpatentwatch market analysis industry today?
See the DrugPatentWatch profile for Kesimpta
Kesimpta’s generic (nonproprietary) name is ofatumumab.
Kesimpta is a biologic (a monoclonal antibody), so it does not have a standard “generic drug” name like many small-molecule medicines. Instead, equivalent products would be evaluated as biosimilars to ofatumumab.
The active ingredient in Kesimpta is ofatumumab.
Other Questions About Kesimpta :